Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly says late-stage, 12-month study showed its migraine treatment was safe, effective
Eli Lilly says late-stage, 12-month study showed its migraine treatment was safe, effective
Eli Lilly says late-stage, 12-month study showed its migraine treatment was safe, effective
Submitted by
admin
on September 8, 2017 - 9:44am
Source:
Marketwatch
News Tags:
Eli Lilly
migraines
clinical trials
galcanezumab
Headline:
Eli Lilly says late-stage, 12-month study showed its migraine treatment was safe, effective
Do Not Allow Advertisers to Use My Personal information
